81192 Ntrk2 translocation analysis
Also known as: NTRK2 translocation testing, NTRK2 fusion detection
Molecular analysis to detect NTRK2 gene rearrangements and translocations associated with various malignancies.
In Plain Language
cancer gene test; cancer translocation screening
Clinical Context
Employed to identify NTRK2 fusions in tumors to determine eligibility for NTRK-targeted therapeutic strategies.
RVU Information
CPT 81192 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81192?
CPT 81192 (Ntrk2 translocation analysis) is a Pathology & Lab code. Molecular analysis to detect NTRK2 gene rearrangements and translocations associated with various malignancies.
Who uses CPT code 81192?
CPT 81192 is used by Oncology, Pathology, Molecular Medicine. Employed to identify NTRK2 fusions in tumors to determine eligibility for NTRK-targeted therapeutic strategies.
When is CPT 81192 used?
Employed to identify NTRK2 fusions in tumors to determine eligibility for NTRK-targeted therapeutic strategies.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.